Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrazoxane for Cardiac Protection in Breast Cancer
NCT00955890Phase 2Terminated
- Sponsor
- Fudan University
- Start
- Jun 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexrazoxane in anthracycline-induced cardiotoxicity, sponsored by Fudan University. Started Jun 2009; status: terminated.
02
Drugs
dexrazoxane
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT00955890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955890.